| 1. |
Kanda J, Ichinohe T, Fuji S, Maeda Y, Ohashi K, Fukuda T, Miyamura K, Iwato K, Eto T, Hirohisa Nakamae H, Kobayashi N, Mori T, Mori SI, Morishima Y, Atsuta Y, Kanda Y on behalf of the HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation. The impact of HLA mismatch direction on the outcome of unrelated bone marrow transplantation: A retrospective analysis from the JSHCT. Biol Blood Marrow Transplant. 2015 Feb; 21(2):305-11. |
| 2. |
Morishima Y, Kashiwase K, Matsuo K, Azuma F, Morishima S, Onizuka M, Yabe T, Murata M, Doki N, Eto T, Mori T, Miyamura K, Sao H, Ichinohe T, Saji H, Kato S, Atsuta Y, Kawa K, Kodera Y, Sasazuki T. Biological significance of HLA locus matching in unrelated donor bone marrow transplantation. Blood. 2015 Feb; 125(7):1189-97. |
| 3. |
Nakasone N, Fukuda T, Kanda J, Mori T, Yano S, Kobayashi T, Miyamura K, Eto T, Kanamori H, Iwato K, Uchida N, Mori SI, Nagamura-Inoue T, Ichinohe T, Atsuta Y, Teshima T, Murata M. Impact of conditioning intensity and total body irradiation on acute graft-versus-host disease after hematopoietic cell transplantation. Bone Marrow Transplant. 2015 Apr; 50(4):559-65. |
| 4. |
Aoki T, Suzuki R, Kuwatsuka Y, Kako S, Fujimoto K, Taguchi J, Kondo T, Ohata K, Ito T, Kamoda Y, Fukuda T, Ichinohe T, Takeuchi K, Izutsu K, Suzumiya J. Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm. Blood. 2015 Jun 4; 125(23):3559-62. |
| 5. |
Fuji S, Kanda J, Kato S, Ikegame K, Morishima S, Miyamoto T, Hidaka M, Kubo K, Miyamura K, Tsudo M, Kobayashi H, Maesako Y, Eto T, Adachi S, Ichinohe T, Atsuta Y, Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation. A Single high-resolution HLA mismatch has a similar adverse impact on the outcome of related hematopoientic stem cell transplantation as a single low-resolution HLA mismatch. Am J Hematol. 2015 Jul; 90(7):618-23. |
| 6. |
Yoshioka S, Miura Y, Iwasa M, Fujishiro A, Yao H, Miura M, Fukuoka M, Nakagawa Y, Yokota A, Hirai H, Ichinohe T, Takaori-Kondo A, Maekawa T. Isolation of mesenchymal stromal/stem cells from small-volume umbilical cord blood units that do not qualify for the banking system. Int J Hematol. 2015 Aug; 102(2):218 |
| 7. |
Takenaka K, Nishida T, Asano-Mori Y, Oshima K, Ohashi K, Mori T, Kanamori H, Miyamura K, Kato C, Kobayashi N, Uchida N, Nakamae H, Ichinohe T, Morishima Y, Suzuki R, Yamaguchi T, Fukuda T; Cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation is associated with a reduced risk of relapse in patients with acute myeloid leukemia who survived to day 100 after transplantation: the Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group. Biol Blood Marrow Transplant. 2015 Nov; 21(11):2008-16. |
| 8. |
Arai Y, Aoki K, Takeda J, Kondo T, Eto T, Ota S, Hashimoto H, Fukuda T, Ozawa Y, Kanda Y, Kato C, Kurokawa M, Iwato K, Onizuka M, Ichinohe T, Atsuta Y, Takami A; AML and MDS Working Group of Japan Society for Hematopoietic Cell Transplantation: Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy. J Hematol Oncol. 2015 Sep 4; 8:10 |
| 9. |
Miura Y, Ichinohe T, Maekawa T. Human Mesenchymal Stromal/Stem Cell-Mediated Bone Marrow Organization. Japanese Journal of Transfusion and Cell Therapy. 2015 Oct; 61(5): 489-490 |
| 10. |
Okamura I, Imai H, Mori K, Ogura K, Isoda A, Mihara K, Matsumoto M, Saito R, Takahashi T, Ikeda T. Rituximab monotherapy as a first-line treatment for pulmonary mucosa-associated lymphoid tissue lymphoma. Int J Hematol. 2015 Jan; 101(1):46-51. |
| 11. |
Yuan Y, Makita N, Cao D, Mihara K, Kadomatsu K, Takei Y. Atelocollagen-mediated intravenous siRNA delivery specific to tumor tissues orthotopically xenografted in prostates of nude mice and its anticancer effects. Nucleic Acid Ther. 2015 Apr; 25(2):85-94. |
| 12. |
Aoki T, Shimada K, Suzuki R, Izutsu K, Tomita A, Maeda Y, Takizawa J, Mitani K, Igarashi T, Sakai K, Miyazaki K, Mihara K, Ohmachi K, Nakamura N, Takasaki H, Kiyoi H, Nakamura S, Kinoshita T, Ogura M. High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma. Blood Cancer J. 2015; EPub 2015 Dec 4 |
| 13. |
Sato M, Kako S, Matsumoto K, Oshima K, Akahoshi Y, Nakano H, Ugai T, Yamasaki R, Wada H, Ishihara Y, Sakamoto K, Kawamura K, Ashizawa M, Terasako-Saito K, Kimura S, Nakasone H, Kikuchi M, Tanihara A, Yamazaki R, Tanaka Y, Kanda J, Nishida J, Morita K, Kanda Y. Pharmacokinetics study of once-daily intravenous busulfan in conditioning regimens for hematopoietic stem cell transplantation. Int J Hematol. 2015 May; 101(5):497-504. |
| 14. |
Imagawa J, Tanaka H, Okada M, nakamae H, Hino M, Murai K, Ishida Y, Kumagai T, Sato S, Ohashi K, Sakamaki H, Wakita H, Uoshima N, Nakagawa Y, Minami Y, Ogasawara M, Takeoka T, akasaka H, Utsumi T, Uike N, Sato T, Ando S, Usuki K, Morita S, Sakamoto J, Kimura S; DADI Trial Group. Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep moleculer response for longer than 1 year (DADI trial): a multicenter phase 2 trial. Lancet Haematol. 2015 Dec 2;2(12): e528-35. |
| 15. |
Iida S, Narita T, Inagaki A, Kobayashi T, Kuroda Y, Fukushima T, Nezu M, Fuchida S, Hirotaka Sakai, Sekiguchi N, Isamu Sugiura I, Maeda Y, Takamatsu H, Tsukamoto N, Maruyama D, Kubota Y, Kojima M, Sunami K, Ono T, Ri M, Tobinai K. T(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs. Blood Cancer Journal 2015 Feb 27;5 :e285 |
| 16. |
Takasu M, Kaichi Y, Tani C, Date S, Akiyama Y, Kuroda Y, Sakai A, Awai K. Iterative Decomposition of Water and Fat with Echo Asymmetry and Least-Squares Estimation (IDEAL) Magnetic Resonance Imaging as a Biomarker for Symptomatic Multiple Myeloma. PLoS One. 2015 Feb 23;10(2): e011684 |
